instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'TISAGENLECLEUCEL'? | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | 1.2X10E9 VIABLE CELLS, ONCE/SINGLE | DrugDosageText | CC BY | 34064196 | 20,297,775 | 2021-05-21 |
What was the dosage of drug 'VINCRISTINE'? | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | R-CHOP REGIMEN | DrugDosageText | CC BY | 34064196 | 20,333,776 | 2021-05-21 |
What was the outcome of reaction 'Coombs negative haemolytic anaemia'? | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | Recovered | ReactionOutcome | CC BY | 34064196 | 20,333,776 | 2021-05-21 |
What was the outcome of reaction 'Neurotoxicity'? | Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy.
BACKGROUND
Chimeric antigen receptor (CAR) T-cells are changing the therapeutic landscape of hematologic malignancies. Severe side effects include cytokine release syndrome (CRS) and immune effector cell-asso... | Recovering | ReactionOutcome | CC BY | 34064196 | 20,333,776 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Venoocclusive disease'. | Shear Wave Elastography in the Detection of Sinusoidal Obstruction Syndrome in Adult Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation.
Hepatic sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD) can be a life-threatening complication after hematopoietic stem cell trans... | BUSULFAN, CYCLOPHOSPHAMIDE | DrugsGivenReaction | CC BY | 34064217 | 20,018,646 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Venoocclusive liver disease'. | Shear Wave Elastography in the Detection of Sinusoidal Obstruction Syndrome in Adult Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation.
Hepatic sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD) can be a life-threatening complication after hematopoietic stem cell trans... | BUSULFAN, CYCLOPHOSPHAMIDE | DrugsGivenReaction | CC BY | 34064217 | 20,018,764 | 2021-05-21 |
What was the outcome of reaction 'Venoocclusive disease'? | Shear Wave Elastography in the Detection of Sinusoidal Obstruction Syndrome in Adult Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation.
Hepatic sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD) can be a life-threatening complication after hematopoietic stem cell trans... | Fatal | ReactionOutcome | CC BY | 34064217 | 20,018,646 | 2021-05-21 |
What was the outcome of reaction 'Venoocclusive liver disease'? | Shear Wave Elastography in the Detection of Sinusoidal Obstruction Syndrome in Adult Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation.
Hepatic sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease (VOD) can be a life-threatening complication after hematopoietic stem cell trans... | Fatal | ReactionOutcome | CC BY | 34064217 | 20,018,764 | 2021-05-21 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Contraindicated product administered'. | Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers.
In Belgium, linezolid is indicated for pneumonia and skin and soft tissue infections, but is more broadly used, due to its oral bioavailability and activity against multiresistant organisms. This could increase... | DULOXETINE, LINEZOLID, TRAZODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34064418 | 20,064,616 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Inappropriate antidiuretic hormone secretion'. | Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers.
In Belgium, linezolid is indicated for pneumonia and skin and soft tissue infections, but is more broadly used, due to its oral bioavailability and activity against multiresistant organisms. This could increase... | LINEZOLID | DrugsGivenReaction | CC BY | 34064418 | 20,054,500 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Incorrect product administration duration'. | Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers.
In Belgium, linezolid is indicated for pneumonia and skin and soft tissue infections, but is more broadly used, due to its oral bioavailability and activity against multiresistant organisms. This could increase... | LINEZOLID | DrugsGivenReaction | CC BY | 34064418 | 20,061,776 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers.
In Belgium, linezolid is indicated for pneumonia and skin and soft tissue infections, but is more broadly used, due to its oral bioavailability and activity against multiresistant organisms. This could increase... | LINEZOLID | DrugsGivenReaction | CC BY | 34064418 | 20,061,776 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers.
In Belgium, linezolid is indicated for pneumonia and skin and soft tissue infections, but is more broadly used, due to its oral bioavailability and activity against multiresistant organisms. This could increase... | LINEZOLID | DrugsGivenReaction | CC BY | 34064418 | 20,063,490 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers.
In Belgium, linezolid is indicated for pneumonia and skin and soft tissue infections, but is more broadly used, due to its oral bioavailability and activity against multiresistant organisms. This could increase... | LINEZOLID | DrugsGivenReaction | CC BY | 34064418 | 20,063,490 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Serotonin syndrome'. | Clinical Use and Adverse Drug Reactions of Linezolid: A Retrospective Study in Four Belgian Hospital Centers.
In Belgium, linezolid is indicated for pneumonia and skin and soft tissue infections, but is more broadly used, due to its oral bioavailability and activity against multiresistant organisms. This could increase... | DULOXETINE, LINEZOLID, TRAZODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34064418 | 20,064,616 | 2021-05-04 |
What was the administration route of drug 'FUROSEMIDE'? | The Spectrum of COVID-19-Associated Myocarditis: A Patient-Tailored Multidisciplinary Approach.
BACKGROUND
Myocarditis lacks systematic characterization in COVID-19 patients.
METHODS
We enrolled consecutive patients with newly diagnosed myocarditis in the context of COVID-19 infection. Diagnostic and treatment strate... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34064463 | 19,922,652 | 2021-05-04 |
What was the administration route of drug 'SPIRONOLACTONE'? | The Spectrum of COVID-19-Associated Myocarditis: A Patient-Tailored Multidisciplinary Approach.
BACKGROUND
Myocarditis lacks systematic characterization in COVID-19 patients.
METHODS
We enrolled consecutive patients with newly diagnosed myocarditis in the context of COVID-19 infection. Diagnostic and treatment strate... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34064463 | 19,922,917 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment.
SARS-CoV-2 nasopharyngeal shedding contributes to the spread of the COVID-19 epidemic. Among 3271 COVID-19 patients treated at the Hospital University Institute Méditerranée Infection, Marseille, France from 3 March to 27 ... | HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 34065871 | 19,742,470 | 2021-05-12 |
What was the administration route of drug 'HYDROXYCHLOROQUINE'? | SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment.
SARS-CoV-2 nasopharyngeal shedding contributes to the spread of the COVID-19 epidemic. Among 3271 COVID-19 patients treated at the Hospital University Institute Méditerranée Infection, Marseille, France from 3 March to 27 ... | Oral | DrugAdministrationRoute | CC BY | 34065871 | 19,742,470 | 2021-05-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | Two Candida auris Cases in Germany with No Recent Contact to Foreign Healthcare-Epidemiological and Microbiological Investigations.
Candida auris has become a global fungal public health threat. This multidrug-resistant yeast is associated with nosocomial intra- and interhospital transmissions causing healthcare-associ... | FLUCONAZOLE, VORICONAZOLE | DrugsGivenReaction | CC BY | 34066140 | 19,441,039 | 2021-05-12 |
What was the outcome of reaction 'Drug resistance'? | Two Candida auris Cases in Germany with No Recent Contact to Foreign Healthcare-Epidemiological and Microbiological Investigations.
Candida auris has become a global fungal public health threat. This multidrug-resistant yeast is associated with nosocomial intra- and interhospital transmissions causing healthcare-associ... | Not recovered | ReactionOutcome | CC BY | 34066140 | 19,441,039 | 2021-05-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood alkaline phosphatase increased'. | Bone Effect and Safety of One-Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study.
In 32-kidney transplanted patients (KTxps), the safety and the effects on BMD and mineral metabolism (MM) of one-year treatment with denosumab (DB) were studied. Femoral and vertebral BMD... | AZATHIOPRINE, CALCIUM, CHOLECALCIFEROL, CINACALCET HYDROCHLORIDE, CYCLOSPORINE, DENOSUMAB, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 34066345 | 19,208,658 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood calcium decreased'. | Bone Effect and Safety of One-Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study.
In 32-kidney transplanted patients (KTxps), the safety and the effects on BMD and mineral metabolism (MM) of one-year treatment with denosumab (DB) were studied. Femoral and vertebral BMD... | AZATHIOPRINE, CALCIUM, CHOLECALCIFEROL, CINACALCET HYDROCHLORIDE, CYCLOSPORINE, DENOSUMAB, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 34066345 | 19,208,658 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood parathyroid hormone increased'. | Bone Effect and Safety of One-Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study.
In 32-kidney transplanted patients (KTxps), the safety and the effects on BMD and mineral metabolism (MM) of one-year treatment with denosumab (DB) were studied. Femoral and vertebral BMD... | AZATHIOPRINE, CALCIUM, CHOLECALCIFEROL, CINACALCET HYDROCHLORIDE, CYCLOSPORINE, DENOSUMAB, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 34066345 | 19,208,658 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Bone Effect and Safety of One-Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study.
In 32-kidney transplanted patients (KTxps), the safety and the effects on BMD and mineral metabolism (MM) of one-year treatment with denosumab (DB) were studied. Femoral and vertebral BMD... | AZATHIOPRINE, CALCIUM, CHOLECALCIFEROL, CINACALCET HYDROCHLORIDE, CYCLOSPORINE, DENOSUMAB, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 34066345 | 19,208,658 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteoporosis'. | Bone Effect and Safety of One-Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study.
In 32-kidney transplanted patients (KTxps), the safety and the effects on BMD and mineral metabolism (MM) of one-year treatment with denosumab (DB) were studied. Femoral and vertebral BMD... | AZATHIOPRINE, CALCIUM, CHOLECALCIFEROL, CINACALCET HYDROCHLORIDE, CYCLOSPORINE, DENOSUMAB, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 34066345 | 19,208,658 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathological fracture'. | Bone Effect and Safety of One-Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study.
In 32-kidney transplanted patients (KTxps), the safety and the effects on BMD and mineral metabolism (MM) of one-year treatment with denosumab (DB) were studied. Femoral and vertebral BMD... | AZATHIOPRINE, CALCIUM, CHOLECALCIFEROL, CINACALCET HYDROCHLORIDE, CYCLOSPORINE, DENOSUMAB, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 34066345 | 19,208,658 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sepsis'. | Bone Effect and Safety of One-Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study.
In 32-kidney transplanted patients (KTxps), the safety and the effects on BMD and mineral metabolism (MM) of one-year treatment with denosumab (DB) were studied. Femoral and vertebral BMD... | AZATHIOPRINE, CALCIUM, CHOLECALCIFEROL, CINACALCET HYDROCHLORIDE, CYCLOSPORINE, DENOSUMAB, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 34066345 | 19,208,658 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract infection'. | Bone Effect and Safety of One-Year Denosumab Therapy in a Cohort of Renal Transplanted Patients: An Observational Monocentric Study.
In 32-kidney transplanted patients (KTxps), the safety and the effects on BMD and mineral metabolism (MM) of one-year treatment with denosumab (DB) were studied. Femoral and vertebral BMD... | AZATHIOPRINE, CALCIUM, CHOLECALCIFEROL, CINACALCET HYDROCHLORIDE, CYCLOSPORINE, DENOSUMAB, MYCOPHENOLIC ACID, TACROLIMUS | DrugsGivenReaction | CC BY | 34066345 | 19,208,658 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Poly-Unsaturated Fatty Acids in ADHD and in Other Neuropsychiatric Conditions: A Multiple Case Presentation.
Neurodevelopmental disorders are seen quite commonly by general pediatricians. They should be managed with a multi-professional approach. The potential beneficial effect of poly-unsaturated fatty acids (PUFAs) h... | METHYLPHENIDATE | DrugsGivenReaction | CC BY | 34066347 | 19,923,010 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyskinesia'. | Poly-Unsaturated Fatty Acids in ADHD and in Other Neuropsychiatric Conditions: A Multiple Case Presentation.
Neurodevelopmental disorders are seen quite commonly by general pediatricians. They should be managed with a multi-professional approach. The potential beneficial effect of poly-unsaturated fatty acids (PUFAs) h... | METHYLPHENIDATE | DrugsGivenReaction | CC BY | 34066347 | 19,923,010 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tic'. | Poly-Unsaturated Fatty Acids in ADHD and in Other Neuropsychiatric Conditions: A Multiple Case Presentation.
Neurodevelopmental disorders are seen quite commonly by general pediatricians. They should be managed with a multi-professional approach. The potential beneficial effect of poly-unsaturated fatty acids (PUFAs) h... | METHYLPHENIDATE | DrugsGivenReaction | CC BY | 34066347 | 19,923,010 | 2021-05-06 |
What was the outcome of reaction 'Dyskinesia'? | Poly-Unsaturated Fatty Acids in ADHD and in Other Neuropsychiatric Conditions: A Multiple Case Presentation.
Neurodevelopmental disorders are seen quite commonly by general pediatricians. They should be managed with a multi-professional approach. The potential beneficial effect of poly-unsaturated fatty acids (PUFAs) h... | Recovered | ReactionOutcome | CC BY | 34066347 | 19,923,010 | 2021-05-06 |
What was the outcome of reaction 'Tic'? | Poly-Unsaturated Fatty Acids in ADHD and in Other Neuropsychiatric Conditions: A Multiple Case Presentation.
Neurodevelopmental disorders are seen quite commonly by general pediatricians. They should be managed with a multi-professional approach. The potential beneficial effect of poly-unsaturated fatty acids (PUFAs) h... | Recovered | ReactionOutcome | CC BY | 34066347 | 19,923,010 | 2021-05-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Corneal disorder'. | Burst of Corneal Dendritic Cells during Trastuzumab and Paclitaxel Treatment.
During breast cancer therapy, paclitaxel and trastuzumab are both associated with adverse effects such as chemotherapy-induced peripheral neuropathy and other systemic side effects including ocular complications. Corneal nerves are considered... | PACLITAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34066952 | 19,428,306 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated adverse reaction'. | Burst of Corneal Dendritic Cells during Trastuzumab and Paclitaxel Treatment.
During breast cancer therapy, paclitaxel and trastuzumab are both associated with adverse effects such as chemotherapy-induced peripheral neuropathy and other systemic side effects including ocular complications. Corneal nerves are considered... | PACLITAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34066952 | 19,942,554 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Keratitis'. | Burst of Corneal Dendritic Cells during Trastuzumab and Paclitaxel Treatment.
During breast cancer therapy, paclitaxel and trastuzumab are both associated with adverse effects such as chemotherapy-induced peripheral neuropathy and other systemic side effects including ocular complications. Corneal nerves are considered... | PACLITAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34066952 | 19,942,554 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuropathy peripheral'. | Burst of Corneal Dendritic Cells during Trastuzumab and Paclitaxel Treatment.
During breast cancer therapy, paclitaxel and trastuzumab are both associated with adverse effects such as chemotherapy-induced peripheral neuropathy and other systemic side effects including ocular complications. Corneal nerves are considered... | PACLITAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34066952 | 19,942,554 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Burst of Corneal Dendritic Cells during Trastuzumab and Paclitaxel Treatment.
During breast cancer therapy, paclitaxel and trastuzumab are both associated with adverse effects such as chemotherapy-induced peripheral neuropathy and other systemic side effects including ocular complications. Corneal nerves are considered... | PACLITAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34066952 | 19,428,306 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ophthalmic herpes simplex'. | Burst of Corneal Dendritic Cells during Trastuzumab and Paclitaxel Treatment.
During breast cancer therapy, paclitaxel and trastuzumab are both associated with adverse effects such as chemotherapy-induced peripheral neuropathy and other systemic side effects including ocular complications. Corneal nerves are considered... | PACLITAXEL, TRASTUZUMAB | DrugsGivenReaction | CC BY | 34066952 | 19,429,157 | 2021-05-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abortion spontaneous'. | Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss.
Recurrent pregnancy loss (RPL) affects up to 6% of couples. Although chromosomal aberrations of the embryos are considered the leading cause, 50% of cases remain unexplained. Antiphospholipid Syndrome is a known c... | ASPIRIN, HYDROXYCHLOROQUINE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34068095 | 20,771,628 | 2021-05-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss.
Recurrent pregnancy loss (RPL) affects up to 6% of couples. Although chromosomal aberrations of the embryos are considered the leading cause, 50% of cases remain unexplained. Antiphospholipid Syndrome is a known c... | ASPIRIN, HYDROXYCHLOROQUINE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34068095 | 20,771,827 | 2021-05-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Normal newborn'. | Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss.
Recurrent pregnancy loss (RPL) affects up to 6% of couples. Although chromosomal aberrations of the embryos are considered the leading cause, 50% of cases remain unexplained. Antiphospholipid Syndrome is a known c... | ASPIRIN, HYDROXYCHLOROQUINE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY | 34068095 | 20,771,827 | 2021-05-13 |
What was the administration route of drug 'ASPIRIN'? | Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss.
Recurrent pregnancy loss (RPL) affects up to 6% of couples. Although chromosomal aberrations of the embryos are considered the leading cause, 50% of cases remain unexplained. Antiphospholipid Syndrome is a known c... | Oral | DrugAdministrationRoute | CC BY | 34068095 | 20,771,827 | 2021-05-13 |
What was the administration route of drug 'HYDROXYCHLOROQUINE'? | Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss.
Recurrent pregnancy loss (RPL) affects up to 6% of couples. Although chromosomal aberrations of the embryos are considered the leading cause, 50% of cases remain unexplained. Antiphospholipid Syndrome is a known c... | Oral | DrugAdministrationRoute | CC BY | 34068095 | 20,771,827 | 2021-05-13 |
What was the dosage of drug 'ASPIRIN'? | Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss.
Recurrent pregnancy loss (RPL) affects up to 6% of couples. Although chromosomal aberrations of the embryos are considered the leading cause, 50% of cases remain unexplained. Antiphospholipid Syndrome is a known c... | 100 MG, QD | DrugDosageText | CC BY | 34068095 | 20,771,827 | 2021-05-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | A Case of Primary Ciliary Dyskinesia Caused by a Mutation in OFD1, Which Was Diagnosed Owing to Clostridium difficile Infection.
We report a Japanese 5-year-old boy with primary ciliary dyskinesia (PCD) which was diagnosed owing to Clostridium difficile (CD) infection caused by prolonged antibiotic exposure. He had int... | AMOXICILLIN\CLAVULANATE POTASSIUM, CLARITHROMYCIN, TOSUFLOXACIN TOSYLATE | DrugsGivenReaction | CC BY | 34068458 | 20,254,359 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | A Case of Primary Ciliary Dyskinesia Caused by a Mutation in OFD1, Which Was Diagnosed Owing to Clostridium difficile Infection.
We report a Japanese 5-year-old boy with primary ciliary dyskinesia (PCD) which was diagnosed owing to Clostridium difficile (CD) infection caused by prolonged antibiotic exposure. He had int... | AMOXICILLIN\CLAVULANIC ACID, CLARITHROMYCIN, TOSUFLOXACIN TOSYLATE | DrugsGivenReaction | CC BY | 34068458 | 20,255,493 | 2021-05-10 |
What was the outcome of reaction 'Clostridium difficile infection'? | A Case of Primary Ciliary Dyskinesia Caused by a Mutation in OFD1, Which Was Diagnosed Owing to Clostridium difficile Infection.
We report a Japanese 5-year-old boy with primary ciliary dyskinesia (PCD) which was diagnosed owing to Clostridium difficile (CD) infection caused by prolonged antibiotic exposure. He had int... | Recovered | ReactionOutcome | CC BY | 34068458 | 20,255,493 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood albumin decreased'. | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | AMPICILLIN, CLINDAMYCIN, DENOSUMAB, SULBACTAM | DrugsGivenReaction | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Folate deficiency'. | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | AMPICILLIN, CLINDAMYCIN, DENOSUMAB, SULBACTAM | DrugsGivenReaction | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis of jaw'. | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | AMPICILLIN, CLINDAMYCIN, DENOSUMAB, SULBACTAM | DrugsGivenReaction | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Prealbumin decreased'. | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | AMPICILLIN, CLINDAMYCIN, DENOSUMAB, SULBACTAM | DrugsGivenReaction | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Protein total decreased'. | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | AMPICILLIN, CLINDAMYCIN, DENOSUMAB, SULBACTAM | DrugsGivenReaction | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Serum ferritin increased'. | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | AMPICILLIN, CLINDAMYCIN, DENOSUMAB, SULBACTAM | DrugsGivenReaction | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transferrin decreased'. | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | AMPICILLIN, CLINDAMYCIN, DENOSUMAB, SULBACTAM | DrugsGivenReaction | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vitamin B12 deficiency'. | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | AMPICILLIN, CLINDAMYCIN, DENOSUMAB, SULBACTAM | DrugsGivenReaction | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vitamin D deficiency'. | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | AMPICILLIN, CLINDAMYCIN, DENOSUMAB, SULBACTAM | DrugsGivenReaction | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Wound dehiscence'. | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | AMPICILLIN, CLINDAMYCIN, DENOSUMAB, SULBACTAM | DrugsGivenReaction | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
What was the outcome of reaction 'Blood albumin decreased'? | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | Not recovered | ReactionOutcome | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
What was the outcome of reaction 'Prealbumin decreased'? | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | Not recovered | ReactionOutcome | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
What was the outcome of reaction 'Transferrin decreased'? | Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ).
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe side effect of mostly antiresorptive drugs. The aim of this prospective clinical study was to evaluate the nutritional status in MRONJ patients scheduled f... | Not recovered | ReactionOutcome | CC BY | 34068498 | 19,680,657 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
Chorea-acanthocytosis (ChAc) is a neurodegenerative disease caused by mutations in the VPS13A gene. It is characterized by several neurological symptoms and the appearance of acanthocytes. Elevated tyrosine kinase Lyn a... | CALCIUM, DASATINIB, LACOSAMIDE, LORAZEPAM, MIDAZOLAM, MIRTAZAPINE, VITAMIN D NOS, ZONISAMIDE | DrugsGivenReaction | CC BY | 34068769 | 20,163,142 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
Chorea-acanthocytosis (ChAc) is a neurodegenerative disease caused by mutations in the VPS13A gene. It is characterized by several neurological symptoms and the appearance of acanthocytes. Elevated tyrosine kinase Lyn a... | CALCIUM, DASATINIB, LACOSAMIDE, LORAZEPAM, MIDAZOLAM, MIRTAZAPINE, VITAMIN D NOS, ZONISAMIDE | DrugsGivenReaction | CC BY | 34068769 | 20,163,142 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
Chorea-acanthocytosis (ChAc) is a neurodegenerative disease caused by mutations in the VPS13A gene. It is characterized by several neurological symptoms and the appearance of acanthocytes. Elevated tyrosine kinase Lyn a... | CLOBAZAM, DASATINIB, LEVETIRACETAM, VALPROIC ACID, VITAMIN D NOS, ZONISAMIDE | DrugsGivenReaction | CC BY | 34068769 | 20,368,752 | 2021-05-10 |
What was the administration route of drug 'DASATINIB'? | Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
Chorea-acanthocytosis (ChAc) is a neurodegenerative disease caused by mutations in the VPS13A gene. It is characterized by several neurological symptoms and the appearance of acanthocytes. Elevated tyrosine kinase Lyn a... | Oral | DrugAdministrationRoute | CC BY | 34068769 | 20,190,107 | 2021-05-10 |
What was the dosage of drug 'LORAZEPAM'? | Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
Chorea-acanthocytosis (ChAc) is a neurodegenerative disease caused by mutations in the VPS13A gene. It is characterized by several neurological symptoms and the appearance of acanthocytes. Elevated tyrosine kinase Lyn a... | UNK, PRN | DrugDosageText | CC BY | 34068769 | 20,163,142 | 2021-05-10 |
What was the dosage of drug 'MIDAZOLAM'? | Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
Chorea-acanthocytosis (ChAc) is a neurodegenerative disease caused by mutations in the VPS13A gene. It is characterized by several neurological symptoms and the appearance of acanthocytes. Elevated tyrosine kinase Lyn a... | UNK, PRN | DrugDosageText | CC BY | 34068769 | 20,163,142 | 2021-05-10 |
What was the outcome of reaction 'Haematocrit decreased'? | Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
Chorea-acanthocytosis (ChAc) is a neurodegenerative disease caused by mutations in the VPS13A gene. It is characterized by several neurological symptoms and the appearance of acanthocytes. Elevated tyrosine kinase Lyn a... | Recovered | ReactionOutcome | CC BY | 34068769 | 20,190,107 | 2021-05-10 |
What was the outcome of reaction 'Red blood cell count decreased'? | Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
Chorea-acanthocytosis (ChAc) is a neurodegenerative disease caused by mutations in the VPS13A gene. It is characterized by several neurological symptoms and the appearance of acanthocytes. Elevated tyrosine kinase Lyn a... | Recovered | ReactionOutcome | CC BY | 34068769 | 20,190,107 | 2021-05-10 |
What was the outcome of reaction 'Thrombocytopenia'? | Targeting Lyn Kinase in Chorea-Acanthocytosis: A Translational Treatment Approach in a Rare Disease.
Chorea-acanthocytosis (ChAc) is a neurodegenerative disease caused by mutations in the VPS13A gene. It is characterized by several neurological symptoms and the appearance of acanthocytes. Elevated tyrosine kinase Lyn a... | Recovered | ReactionOutcome | CC BY | 34068769 | 20,190,107 | 2021-05-10 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood creatinine increased'. | Transgender Person and Pre-Exposure Prophylaxis for HIV: A Renal Dilemma.
Sexual health care for transgender people is often inadequate and not addressed. Targeted prevention approaches that respond to the specific needs of transgender individuals are essential to reducing HIV infections. HIV prophylaxis is a proven in... | FOLIC ACID, MAGNESIUM OXIDE, MELATONIN, TESTOSTERONE, VITAMIN D NOS | DrugsGivenReaction | CC BY | 34069372 | 19,937,635 | 2021-05-19 |
What was the administration route of drug 'TESTOSTERONE'? | Transgender Person and Pre-Exposure Prophylaxis for HIV: A Renal Dilemma.
Sexual health care for transgender people is often inadequate and not addressed. Targeted prevention approaches that respond to the specific needs of transgender individuals are essential to reducing HIV infections. HIV prophylaxis is a proven in... | Topical | DrugAdministrationRoute | CC BY | 34069372 | 19,937,635 | 2021-05-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | AMPHOTERICIN B, BICTEGRAVIR SODIUM\EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE, DOLUTEGRAVIR SODIUM\RILPIVIRINE HYDROCHLORIDE, EMTRICITABINE, FLUCONAZOLE, FLUCYTOSINE, ISAVUCONAZOLE | DrugsGivenReaction | CC BY | 34071211 | 19,441,727 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Genotype drug resistance test positive'. | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | AMPHOTERICIN B, BICTEGRAVIR SODIUM\EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE, DOLUTEGRAVIR SODIUM\RILPIVIRINE HYDROCHLORIDE, EMTRICITABINE, FLUCONAZOLE, FLUCYTOSINE, ISAVUCONAZOLE | DrugsGivenReaction | CC BY | 34071211 | 19,441,727 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune reconstitution inflammatory syndrome'. | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | AMPHOTERICIN B, BICTEGRAVIR SODIUM\EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE, DOLUTEGRAVIR SODIUM\RILPIVIRINE HYDROCHLORIDE, EMTRICITABINE, FLUCONAZOLE, FLUCYTOSINE, ISAVUCONAZOLE | DrugsGivenReaction | CC BY | 34071211 | 19,441,727 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional dose omission'. | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | AMPHOTERICIN B, BICTEGRAVIR SODIUM\EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE, DOLUTEGRAVIR SODIUM\RILPIVIRINE HYDROCHLORIDE, EMTRICITABINE, FLUCONAZOLE, FLUCYTOSINE, ISAVUCONAZOLE | DrugsGivenReaction | CC BY | 34071211 | 19,441,727 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional overdose'. | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | AMPHOTERICIN B, EMTRICITABINE, FLUCONAZOLE, FLUCYTOSINE, ISAVUCONAZOLE, PREDNISOLONE | DrugsGivenReaction | CC BY | 34071211 | 19,553,632 | 2021-05-28 |
What was the administration route of drug 'AMPHOTERICIN B'? | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34071211 | 19,780,539 | 2021-05-28 |
What was the administration route of drug 'FLUCYTOSINE'? | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34071211 | 19,780,539 | 2021-05-28 |
What was the dosage of drug 'BICTEGRAVIR SODIUM\EMTRICITABINE\TENOFOVIR ALAFENAMIDE FUMARATE'? | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | DAYS 26 TO 50 | DrugDosageText | CC BY | 34071211 | 19,441,727 | 2021-05-28 |
What was the outcome of reaction 'Blood HIV RNA increased'? | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | Recovered | ReactionOutcome | CC BY | 34071211 | 19,780,539 | 2021-05-28 |
What was the outcome of reaction 'Immune reconstitution inflammatory syndrome'? | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | Recovered | ReactionOutcome | CC BY | 34071211 | 19,441,727 | 2021-05-28 |
What was the outcome of reaction 'Intentional dose omission'? | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | Recovered | ReactionOutcome | CC BY | 34071211 | 19,441,727 | 2021-05-28 |
What was the outcome of reaction 'Virologic failure'? | Successful Treatment of Cryptococcal Meningitis and Cryptococcoma with Isavuconazole in a Patient Living with HIV.
We describe the successful use of isavuconazole for treatment of an HIV-positive patient with cryptococcal meningitis following induction therapy with liposomal amphotericin B and flucytosine. Because the ... | Recovered | ReactionOutcome | CC BY | 34071211 | 19,780,539 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva®) Related Osteonecrosis of the Jaw: A Retrospective Study.
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive medication. The aim of this study was to evaluate the incidence of denosumab-related osteonecr... | DENOSUMAB | DrugsGivenReaction | CC BY | 34071481 | 19,415,068 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Device failure'. | A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva®) Related Osteonecrosis of the Jaw: A Retrospective Study.
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive medication. The aim of this study was to evaluate the incidence of denosumab-related osteonecr... | DENOSUMAB | DrugsGivenReaction | CC BY | 34071481 | 19,415,068 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Injury associated with device'. | A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva®) Related Osteonecrosis of the Jaw: A Retrospective Study.
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive medication. The aim of this study was to evaluate the incidence of denosumab-related osteonecr... | DENOSUMAB | DrugsGivenReaction | CC BY | 34071481 | 19,415,068 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis of jaw'. | A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva®) Related Osteonecrosis of the Jaw: A Retrospective Study.
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive medication. The aim of this study was to evaluate the incidence of denosumab-related osteonecr... | DENOSUMAB | DrugsGivenReaction | CC BY | 34071481 | 19,415,068 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tooth extraction'. | A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva®) Related Osteonecrosis of the Jaw: A Retrospective Study.
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive medication. The aim of this study was to evaluate the incidence of denosumab-related osteonecr... | DENOSUMAB | DrugsGivenReaction | CC BY | 34071481 | 19,415,068 | 2021-05-28 |
What was the outcome of reaction 'Death'? | A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva®) Related Osteonecrosis of the Jaw: A Retrospective Study.
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive medication. The aim of this study was to evaluate the incidence of denosumab-related osteonecr... | Fatal | ReactionOutcome | CC BY | 34071481 | 19,415,068 | 2021-05-28 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal failure'. | Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives.
Cefiderocol is a new cephalosporin displaying against extensively resistant (XDR) Gram-negative bacteria. We report our experience with cefiderocol-based combination therapies a... | COLISTIN, FOSFOMYCIN, MEROPENEM | DrugsGivenReaction | CC BY | 34072342 | 19,435,972 | 2021-05-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary tract toxicity'. | Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix.
The clinical significance of carbon-ion radiotherapy (CIRT) for adenocarcinoma (AC) of the uterine cervix has been assessed in several single-institutional studies. To validate ... | CISPLATIN, RADIATION THERAPY | DrugsGivenReaction | CC BY | 34072676 | 20,126,874 | 2021-05-31 |
What was the administration route of drug 'CISPLATIN'? | Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix.
The clinical significance of carbon-ion radiotherapy (CIRT) for adenocarcinoma (AC) of the uterine cervix has been assessed in several single-institutional studies. To validate ... | Intravenous drip | DrugAdministrationRoute | CC BY | 34072676 | 20,125,186 | 2021-05-31 |
What was the dosage of drug 'CISPLATIN'? | Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix.
The clinical significance of carbon-ion radiotherapy (CIRT) for adenocarcinoma (AC) of the uterine cervix has been assessed in several single-institutional studies. To validate ... | 40 MG/M2, UP TO FIVE COURSES | DrugDosageText | CC BY | 34072676 | 20,126,874 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cataract'. | Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
This study compared the outcomes of cataract surgery with intraocular lens (IOL) implantation in patients with juvenile idiopathic arthritis (JIA)-associated chronic anteri... | ADALIMUMAB, AZATHIOPRINE, METHOTREXATE | DrugsGivenReaction | CC BY | 34072679 | 20,561,706 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cyclitic membrane'. | Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
This study compared the outcomes of cataract surgery with intraocular lens (IOL) implantation in patients with juvenile idiopathic arthritis (JIA)-associated chronic anteri... | ADALIMUMAB, AZATHIOPRINE, METHOTREXATE | DrugsGivenReaction | CC BY | 34072679 | 20,561,706 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug specific antibody present'. | Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
This study compared the outcomes of cataract surgery with intraocular lens (IOL) implantation in patients with juvenile idiopathic arthritis (JIA)-associated chronic anteri... | ADALIMUMAB, AZATHIOPRINE, METHOTREXATE | DrugsGivenReaction | CC BY | 34072679 | 20,561,706 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intraocular pressure increased'. | Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
This study compared the outcomes of cataract surgery with intraocular lens (IOL) implantation in patients with juvenile idiopathic arthritis (JIA)-associated chronic anteri... | ADALIMUMAB, AZATHIOPRINE, METHOTREXATE | DrugsGivenReaction | CC BY | 34072679 | 20,561,706 | 2021-05-31 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Iris adhesions'. | Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy.
This study compared the outcomes of cataract surgery with intraocular lens (IOL) implantation in patients with juvenile idiopathic arthritis (JIA)-associated chronic anteri... | ADALIMUMAB, AZATHIOPRINE, METHOTREXATE | DrugsGivenReaction | CC BY | 34072679 | 20,561,706 | 2021-05-31 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.